Next Article in Journal
The Formation of pH-Sensitive Wormlike Micelles in Ionic Liquids Driven by the Binding Ability of Anthranilic Acid
Next Article in Special Issue
A Protease Inhibitor with Induction Therapy with Natural Interferon-β in Patients with HCV Genotype 1b Infection
Previous Article in Journal
Molecular Biology of the Cell, Sixth Edition; ISBN: 9780815344643; and Molecular Biology of the Cell, Sixth Edition, The Problems Book; ISBN 9780815344537
Previous Article in Special Issue
Epidemiology of Hepatitis E Virus in European Countries
Review

Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation

by 1,2,*, 1,2 and 1,2
1
Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan
2
School of Medicine, National Yang Ming University, Taipei 100, Taiwan
*
Author to whom correspondence should be addressed.
Academic Editor: Tatsuo Kanda
Int. J. Mol. Sci. 2015, 16(12), 28126-28145; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms161226087
Received: 30 July 2015 / Revised: 3 November 2015 / Accepted: 9 November 2015 / Published: 26 November 2015
(This article belongs to the Special Issue Viral Hepatitis Research)
Chronic hepatitis B virus (HBV) infection is a major global health problem with an estimated 400 million HBV carriers worldwide. In the natural history of chronic hepatitis B (CHB), spontaneous acute exacerbation (AE) is not uncommon, with a cumulative incidence of 10%–30% every year. While exacerbations can be mild, some patients may develop hepatic decompensation and even die. The underlying pathogenesis is possibly related to the activation of cytotoxic T lymphocyte-mediated immune response against HBV. An upsurge of serum HBV DNA usually precedes the rise of alanine aminotransferase (ALT) and bilirubin. Whether antiviral treatment can benefit CHB with severe AE remains controversial, but early nucleos(t)ide analogues treatment seemed to be associated with an improved outcome. There has been no randomized study that compared the effects of different nucleos(t)ide analogues (NA) in the setting of CHB with severe AE. However, potent NAs with good resistance profiles are recommended. In this review, we summarized current knowledge regarding the natural history, pathogenetic mechanisms, and therapeutic options of CHB with severe AE. View Full-Text
Keywords: hepatitis B; acute exacerbation; antiviral treatment hepatitis B; acute exacerbation; antiviral treatment
Show Figures

Figure 1

MDPI and ACS Style

Tsai, W.-L.; Sun, W.-C.; Cheng, J.-S. Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation. Int. J. Mol. Sci. 2015, 16, 28126-28145. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms161226087

AMA Style

Tsai W-L, Sun W-C, Cheng J-S. Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation. International Journal of Molecular Sciences. 2015; 16(12):28126-28145. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms161226087

Chicago/Turabian Style

Tsai, Wei-Lun, Wei-Chi Sun, and Jin-Shiung Cheng. 2015. "Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation" International Journal of Molecular Sciences 16, no. 12: 28126-28145. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms161226087

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop